Tcelna

This page shows the latest Tcelna news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA drops Ono-partnered multiple sclerosis drug

It also has a licensing deal in place for Tcelna (imilecleucel-T), a personalised treatment for secondary-progressive MS developed by Opexa Therapeutics that is in phase IIb testing with

Latest news

Currencies hit Merck Serono sales but firm says it is 'on course'

Overall groups sales down to €2.84bn for second quarter of 2013
Merck KGaA to meet 2014 financial targets one year early

and recently-licensed MS drug Tcelna (imilecleucel-T) following the decision to drop brain and lung cancer prospect cilengitide from development in the first quarter.
Merck KGaA and Opexa enter MS deal

Will develop personalised T-cell based medicine Tcelna. Merck KGaA has agreed a deal with Opexa Therapeutics to develop and commercialise a new personalised treatment for multiple sclerosis (MS). ... During the SPMS trial, patients undergo two annual

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Pharma deals during February 2013

sales. In the other option deal, Merck Serono has acquired an option over Opexa Therapeutics' phase IIb Tcelna (imilecleucel-T) vaccine for MS (for all territories except Japan). ... Tcelna is being developed as a personalised therapy specifically

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Experienced medical editor: Competitive salary and bonus scheme

Senior Medical Writer, MedComms Agency: Salary TBC

Publications director: Competitive salary and bonus scheme

Senior External Communications Lead: £Competitive Salary

Account director: Competitive salary and bonus scheme

Account Manager (PR): Great Benefits

Account Manager: £Competitive Salary

Account Director: £Competitive Salary

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Account Director, Medical Education: Salary TBC

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Account Director, Healthcare Communications: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Subscribe to our email news alerts

PMHub

Add my company

Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’: Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019: OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...